-
Nov 19, 2023
Lunaphore Technologies, Cell Signaling Technology Partner on Antibody
NEW YORK – Lunaphore Technologies and Cell Signaling Technology said on
view more -
Nov 17, 2023
MicroRNA
Parasites & Vectors
view more -
Nov 15, 2023
Youngest primary cold agglutinin disease case reported
Study describes 16-year-old girl with primary cold agglutinin disease
view more -
Nov 13, 2023
ELISA Tests: Beyond Just Antibody Detection
Morgana Moretti, PhD, is an active scientist and freelance medical writer with
view more -
Nov 11, 2023
Powerful Cocktail of Modified Antibodies Supercharges the Immune System Against COVID
By Lund UniversityMay 12, 2023 Lund University researchers have modified
view more -
Nov 09, 2023
China Approves the World's First Vaccine against XBB Descendent Lineages of SARS
CHENGDU, China, June 8, 2023 /PRNewswire/ -- On June 8th, 2023, Coviccine®
view more -
Nov 07, 2023
Molecular fate
Nature volume 615, pages
view more -
Nov 05, 2023
Development platforms: Multi
Need more information? Let us help you with your inquiries, brochures and
view more -
Nov 03, 2023
FDA Advisory Committee votes unanimously to confirm clinical benefit of LEQEMBI® (lecanemab
STOCKHOLM, June 10, 2023 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq
view more -
Nov 01, 2023
Study shows Alzheimer’s disease
Dr. Cameron McAlpine To commemorate World Multiple Sclerosis (MS) Day, we speak
view more -
Oct 30, 2023
FDA Approves AbbVie/Genmab's Cancer Drug As First Bispecific Antibody For Type Of Lymphoma In Adult Patients
The FDA has approved Epkinly (epcoritamab-bysp) as the first and only T-cell
view more -
Oct 28, 2023
City of Hope — Developing Bispecific Antibody Therapies to Improve Multiple Myeloma Treatment
By pinpointing genetic vulnerabilities in cancer cells and harnessing the power
view more
RECENT NEWS
SEND YOUR INQUIRY
SUBMIT